The emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies- as well as government agencies- to partner at unprecedented speed to develop vaccines- treatments- and kits
This article covers the last six months of deal data provided by Chris Dokomajilar of DealForma
During the last six months…
